Experimental immune-mediated damage of septal cholinergic neurons

Journal of Neuroimmunology

Volumn 77, Issue 1, 1997, Pages 63-74

  Kálmán, János ^a,b   Engelhardt, József I ^a,b   Le, Wei Dong ^a   Xie, Wenjie ^a   Kovacs, Imre ^b   Kása, Péter ^b   Appel, Stanley H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cholinergic neurons; Diagonal band of Broca; Guinea pig; Immune mediated damage; Learning and memory; Medial septum; Rat

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; IMMUNOGLOBULIN G;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ENZYME ACTIVITY; FOREBRAIN; GUINEA PIG; HIPPOCAMPUS; IMMUNE MEDIATED INJURY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LEARNING; MOUSE; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY;

ALZHEIMER DISEASE; ANIMALS; AUTOIMMUNE DISEASES; BEHAVIOR, ANIMAL; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; CROSS REACTIONS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GUINEA PIGS; HYBRID CELLS; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENTRICULAR; LEARNING; MALE; MEMORY; MICE; NEUROBLASTOMA; PROSENCEPHALON; RATS; SEPTAL NUCLEI;

EID: 18244430801     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00062-3     Document Type: Article

References (52)

1. Aisen, P.S., Davis, K.L., 1994. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am. J. Psychiatry 151 (8), 1105-1143.
2. Appel, S.H., Le, W.D., Tajti, J., Haverkamp, L.J., Engelhardt, J.I., 1992. Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs. Ann. Neurol. 32, 494-501.
3. Arendt, T., Bial, V., Arendt, A., Tennstedt, A., 1983. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol. 61, 101-108.
4. Berkenbosch, F., Biewenga, J., Brouns, M., Rozemuller, J.M., Strijbos, P., van Dam, A.M., 1992. Cytokines and inflammatory proteins in Alzheimer's disease. Res. Immunol. 143, 657-663.
5. Brugge, K., Katzman, R., Hill, L.R., Hausen, L.A., Saitoh, T., 1992. Serological alpha-1 antichymotrypsin in Down's syndrome and Alzheimer's disease. Ann. Neurol. 32, 193-197.
6. Chapman, J., Bachar, O., Korczyn, A.D., Wertman, E., Michaelson, D.M., 1988. Antibodies to cholinergic neurons in Alzheimer's disease. J. Neurochem. 51, 479-485.
7. Chapman, J., Bachar, O., Korczyn, A.D., Wertman, E., Michaelson, D.M., 1989. Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons. Neuroscience 9, 2710-2717.
8. Chapman, J., Alroy, Z., Weiss, M., Faigon, M., Feldon, J., Michaelson, D.M., 1991. Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats. Neuroscience 40 (2), 297-305.
9. Connor, D.J., Langlais, P.J., Thal, L.J., 1991. Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Res. 555, 84-90.
10. Crawford, G.D., Le, W.D., Smith, R.G., Wie, W.J., Appel, S.H., 1992. A novel N18TG2x mesencehalon cell hybrid expresses properties which suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12, 3392-3396.
11. Dahlstrom, A., McRae, A., Polinsky, R., Nee, L., Sadasivan, B., Ling, E.A., 1994. Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies. Mol. Neurobiol. 9 (1-3), 41-54.
12. Dickson, D.W., Lee, S.C., Mattiace, L.A., Yen, S.C., Brosman, C., 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83.
13. Dubovik, V., Faigon, M., Feldon, J., Michaelson, D.M., 1993. Decreased density of forebrain cholinergic neurons in experimental autoimmune dementia (EAD). Neuroscience 56, 75-82.
14. Eikelenboom, P., Abraham, C.R., 1992. Immunological factors in Alzheimer's disease. Res. Immunol. 143, 613-683, 45th Forum in Immunology.
15. Eilam, D., Szechtman, H., Faigon, M., Dubovik, V., Feldon, J., Michaelson, D.M., 1993. Disintegration of the spatial organization of behavior in experimental autoimmune dementia. Neuroscience 56, 83-91.
16. Engelhardt, J.I., Appel, S.H., Killian, J.M., 1989. Experimental autoimmune motoneuron disease. Ann. Neurol. 26, 368-376.
17. Engelhardt, J.I., Appel, S.H., Killian, J.M., 1990. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: Experimental autoimmune gray matter disease. J. Neuroimmunol. 27, 21-31.
18. Fillit, H.M., Luine, V.N., Reisberg, B., Amador, R., McEwen, B., Zabrishie, J.B., 1985. Studies of the specificity of antibrain antibodies in Alzheimer's disease. In: Huttong, J.T., Kenny, A.D. (Eds.), Senile Dementia of the Alzheimer Type. Liss, New York, pp. 307-318.
19. Fillit, H.M., Kemeny, E., Luine, V., Weschler, M.E., Zabriski, J.B., 1987. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. J. Gerontol. 42, 180-184.
20. Foley, P., Bradford, H.F., Dochart, M., Fillet, H., Luine, V.N., McEwen, B., Buch, G., Winblad, B., Hardy, J., 1988. Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease. J. Neurol. 235, 466-471.
21. Fonnum, F., 1969. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. J. Biochem. 115, 465-472.
22. Gaskin, F., Finley, J., Fang, Q., Xu, S., Fu, S., 1993. Human antibodies reactive with B-amyloid protein in Alzheimer's disease. J. Exp. Med. 177, 1181-1186.
23. Gertz, H.J., Cervos-Navarro, J., Ewald, V., 1987. The septo-hippocampal pathway in patients suffering from senile dementia of Alzheimer's type. Evidence for neuronal plasticity?. Neurosci. Lett. 76, 228-232.
24. Giulian, D., Haverkamp, L.J., Li, J., Karshin, W.L., Yu, J., Tom, D., Li, X., Kirkpatrick, J.B., 1995. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer's brain. Neurochem. Int. 27, 119-137.
25. Gray, J.A., McNaughton, N., 1982. Comparison between the behavioral effects of septal and hippocampal lesions: A review. Neurosci. Behav. Rev. 7, 119-188.
26. Haga, S., Akai, K., Ishii, T., 1989. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol. 77, 569-575.
27. Hammond, D.H., Wainer, B.H., Tonsgard, J.H., Heller, A., 1986. Neuronal properties of clonal hybrid cell lines derived from central cholinergic neurons. Science 234, 1234-1240.
28. Kalaria, R.N., 1993. The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol. 3, 333-347.
29. Kiss, J., Patel, A.J., Baimbridge, K.G., Freund, T.F., 1990. Topographical localization of neurons containing parvalbumin and choline acetyltransferase in the medial septum-diagonal band region of the rat. Neuroscience 36, 61-72.
30. Kwapinski, G., 1982. Immunological Assays in the Methodology of Investigative and Clinical Immunology. Robert E. Krieger Publishing, Islabar, FL, pp. 264-266.
31. Le, W.D., Engelhardt, J., Xie, W.J., Schneider, L., Smith, R.G., Appel, S.H., 1995. Experimental autoimmune nigral damage in guinea pigs. J. Neuroimmunol. 57, 45-53.
32. Lee, H.J., Hammond, D.N., Large, T.H., Wainer, B.H., 1990. Immortalized young adult neurons from the septal region: Generation and characterization. Dev. Brain. Res. 52, 219-228.
33. Matsubara, E., Hirai, S., Amari, M., Shoji, M., Yamaguchi, H., Okamoto, K., Ishiguro, K., Harigaya, Y., Wakabayashi, W., 1990. Alpha-1 antichymotripsin as a possible biochemical marker for Alzheimer type dementia. Ann. Neurol. 28, 561-567.
34. McGeer, P.L., McGeer, E.G., Kawamata, T., Yamada, T., Akiyama, H., 1991. Reactions of the immune system in chronic degenerative neurological diseases. Can. J. Neurol. Sci. 18, 376-379.
35. McGeer, P.L., Kawamata, T., Walker, D.G., Akiyama, H., Yooyama, I., McGeer, E.G., 1993. Microglia in degenerative neurological disease. Glia 7, 84-92.
36. McRae-Dequeurce, A., Booj, S., Haglid, N.K., Rosengren, L., Karlsson, J.E., Kalrson, J., Wallin, A., Swennerholm, L., Gottfries, C.G., Dahlstrom, A., 1987. Antibodies in cerebrospinal fluid of some Alzheimer's disease patients recognize cholinergic neurons in the rat central nervous system. Proc. Natl. Acad. Sci. USA 84, 9214-9218.
37. McRae-Dequeurce, A., Ling, E.A., Polinsky, R., Gottfries, C.G., Dahlstrom, A., 1991. Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system. Neuroscience 41, 739-752.
38. Michaelson, D.M., Kadar, T., Weiss, Z., Chapman, J., Feldon, J., 1990. Immunization with cholinergic cell bodies induces histopathological changes in rat brains. Mol. Chem. Neuropathol. 13, 71-80.
39. Morris, R.G.M., 1981. Spatial localization does not require the presence of local cues. Learning Motiv. 12, 239-261.
40. Paxinos, P., Watson, C., 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
41. Riekkinen, M., Riekkinen, P., Riekkinen, P., 1991. Comparison of quisqualic and ibotenic acid nucleus basalis magnocellularis lesions on water-maze and passive avoidance performance. Brain Res. Bull. 27, 119-123.
42. Robbins, T.W., Everitt, B.J., Marston, H.M., Wilkinson, J., Jones, G.H., Page, K.J., 1989. Comparative effects of ibotenic acid and quisqualic acid induced lesions of the substantia innominata on attentional function in the rat: Further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav. Brain Res. 35, 221-240.
43. Serot, J.M., Benet, M.C., Gobert, B., Christmann, D., Leheup, D., Faure, G.C., 1992. Antibodies to choroid plexus in senile dementia of Alzheimer type. J. Clin. Pathol. 45, 781-783.
44. Singh, V.K., Yang, Y., Singh, E.A., 1992. Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients. Neurosci. Lett. 147, 25-28.
45. Singh, V.K., 1994. Studies of neuroimmune markers in Alzheimer's disease. Mol. Neurobiol. 9 (1-3), 73-81.
46. Smith, G., 1988. Animal models of Alzheimer's disease: Experimental cholinergic denervation. Brain Res. Rev. 13, 103-118.
47. Somogyi, P., Takagi, H., 1982. A note on the use of picric acid-paraformaldehyde-glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistry. Neuroscience 7, 1779-1783.
48. Soussan, L., Tchernakov, K., Bacharlan, O., Yuvan, T., Wertman, E., Michaelson, D.M., 1994. Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease. Mol. Neurobiol. 9 (1-3), 83-91.
49. Towbin, H., Gordon, J., 1984. Immunoblotting and dot immunobinding. Current status and outlook. J. Immunol. Methods 72, 313-340.
50. Wainer, B.H., Lee, H.J., Roback, J.D., Hammond, D.N., 1991. In vitro cell cultures as a model of the basal forebrain. In: Napier, T.C. et al. (Eds.), The Basal Forebrain. Plenum Press, New York, pp. 415-434.
51. Wenk, G.L., Harrington, C.A., Tucker, D.A., Ranee, N.B., Walker, L.C., 1992. Basal forebrain neurons and memory: A biochemical, histological and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106, 909-923.
52. Wiley, R.G., Berbos, T.G., Deckwerth, T.L., Johnson, E.M. Jr., Lappi, D.A., 1995. Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: Modeling the cholinergic degeneration of Alzheimer's disease. J. Neurol. Sci. 128, 157-166.